Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Parkinsons Dis ; 5(3): 625-36, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25870025

RESUMEN

Neuropsychiatric symptoms are common non-motor symptoms in Parkinson's disease (PD). Apathy and impulse control disorders (ICD) are two opposite motivational expressions of a continuous behavioural spectrum involving hypo- and hyperdopaminergia. Both syndromes share pathological (decreased vs increased) dopamine receptor stimulation states. Apathy belongs to the spectrum of hypodopaminergic symptoms together with anhedonia, anxiety and depression. Apathy is a key symptom of PD which worsens with disease progression. Animal models, imaging and pharmacological studies concur in pointing out dopaminergic denervation in the aetiology of parkinsonian apathy with a cardinal role of decreased tonic D2/D3 receptor stimulation. ICDs are part of the hyperdopaminergic behavioural spectrum, which also includes punding, and dopamine dysregulation syndrome (DDS), which are all related to non-physiological dopaminergic stimulation induced by antiparkinsonian drugs. According to clinical data tonic D2/D3 receptor stimulation can be sufficient to induce ICDs. Clinical observations in drug addiction and PD as well as data from studies in dopamine depleted rodents provide hints allowing to argue that both pulsatile D1 and D2 receptor stimulation and the severity of dopaminergic denervation are risk factors to develop punding behavior and DDS. Imaging studies have shown that the brain structures involved in drug addiction are also involved in hyperdopaminergic behaviours with increase of bottom-up appetitive drive and decrease in prefrontal top down behavioural control.


Asunto(s)
Apatía/fisiología , Encéfalo/fisiopatología , Trastornos Disruptivos, del Control de Impulso y de la Conducta/fisiopatología , Dopamina/fisiología , Enfermedad de Parkinson/fisiopatología , Enfermedad de Parkinson/psicología , Animales , Estimulación Encefálica Profunda , Modelos Animales de Enfermedad , Trastornos Disruptivos, del Control de Impulso y de la Conducta/complicaciones , Agonistas de Dopamina/administración & dosificación , Humanos , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/terapia , Receptores Dopaminérgicos/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA